Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Hematopoietic Stem Cell Transplantation for Hemophagocytic Lymphohistiocitosis : A National Retrospective Analysis of Data from the Italian Association of Pediatric Hematology Oncology (AIEOP)

Blood (2015) 126 (23): 621.

https://doi.org/10.1182/blood.V126.23.621.621

Published: 2015

Journal Articles

Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Franco Locatelli, Marco Zecca, MD, Gianni Cazzaniga, PhD, Luciana Vinti, MD, Andrea Biondi, Tommaso Mina, MD, Chiara Messina, Rosanna Parasole, Franca Fagioli, MD, Ottavio Ziino, Giuseppe Basso, MD, Riccardo Masetti, MD, Carmelo Rizzari

Blood (2014) 124 (21): 65.

https://doi.org/10.1182/blood.V124.21.65.65

Published: 2014

Journal Articles

Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience

Blood (2014) 124 (21): 1812.

https://doi.org/10.1182/blood.V124.21.1812.1812

Published: 2014

Journal Articles

Role of Allogeneic Hematopoietic Stem Cell Transplantation in t(4;11) Positive Acute Lymphoblastic Leukemia (ALL): A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

Luca Lo Nigro, Marco Zecca, MD, Franca Fagioli, MD, Edoardo Lanino, Chiara Messina, Marco Rabusin, MD, Domenico Ripaldi, MD, Attilio Rovelli, MD, Arcangelo Prete, Franco Locatelli

Blood (2014) 124 (21): 1243.

https://doi.org/10.1182/blood.V124.21.1243.1243

Published: 2014

Journal Articles

Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3703.

https://doi.org/10.1182/blood.V124.21.3703.3703

Published: 2014

Journal Articles

High Dose Imatinib Is Effective In Children and Adolescents With Chronic Myelogenous Leukemia In Chronic Phase. The Italian Experience

Blood (2013) 122 (21): 1490.

https://doi.org/10.1182/blood.V122.21.1490.1490

Published: 2013

Journal Articles

No Major Complications In Children After Stem Cell Donation At One Year Follow-Up: EBMT Pediatric Diseases Working Party Study

Jan Styczynski, MD, PhD, Lidia Gil, MD PhD, Franca Fagioli, MD, Sarah Marktel, MD, Adriana Balduzzi, MD, Daniela Janeckova, Karoline Ehlert, MD, Jean-Hugues Dalle, PhD, MD, Jacek Wachowiak, MD PhD, Maurizio Miano, Chiara Messina, MD, M.A. Diaz, MD, Isabel Badell, Peter Dreger, MD, Giorgio Dini, MD, Christina Peters

Blood (2013) 122 (21): 1725.

https://doi.org/10.1182/blood.V122.21.1725.1725

Published: 2013

Journal Articles

Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry.

Franca Fagioli, MD, Paola Quarello, MD, Marco Zecca, Edoardo Lanino, MD, Carla Rognoni, Adriana Balduzzi, MD, Chiara Messina, MD, Claudio Favre, MD, Roberto Foà, Mimmo Ripaldi, MD, Sergio Rutella, Giuseppe Basso, MD, Arcangelo Prete, Franco Locatelli, Prof, MD, PhD

Blood (2012) 120 (21): 3036.

https://doi.org/10.1182/blood.V120.21.3036.3036

Published: 2012

Journal Articles

Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study

Blood (2012) 119 (12): 2935–2942.

https://doi.org/10.1182/blood-2011-04-349688

Published: 2012

Journal Articles

No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission

Giorgio Dini, Marco Zecca, Adriana Balduzzi, Chiara Messina, Riccardo Masetti, Franca Fagioli, Claudio Favre, Marco Rabusin, Fulvio Porta, Erika Biral, Mimmo Ripaldi, Anna Paola Iori, Carla Rognoni, Arcangelo Prete, Franco Locatelli

Blood (2011) 118 (25): 6683–6690.

https://doi.org/10.1182/blood-2011-05-354233

Published: 2011

Includes: Supplemental data

Journal Articles

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Blood (2011) 118 (8): 2077–2084.

https://doi.org/10.1182/blood-2011-03-338707

Published: 2011

Includes: Supplemental data

Journal Articles

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Blood (2011) 118 (6): 1693–1698.

https://doi.org/10.1182/blood-2011-02-336156

Published: 2011

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Blood (2010) 116 (21): 3460.

https://doi.org/10.1182/blood.V116.21.3460.3460

Published: 2010

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study

Blood (2010) 116 (21): 2322.

https://doi.org/10.1182/blood.V116.21.2322.2322

Published: 2010

Journal Articles

Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT

Andrée-Laure Herr, Nabil Kabbara, Carmem M. S. Bonfim, Pierre Teira, Franco Locatelli, Karin Tiedemann, Arjan Lankester, Jean-Pierre Jouet, Chiara Messina, Yves Bertrand, Cristina Díaz de Heredia, Christina Peters, Wagnara Chaves, Samir K. Nabhan, Irina Ionescu, Eliane Gluckman, Vanderson Rocha

Blood (2010) 116 (11): 1849–1856.

https://doi.org/10.1182/blood-2010-02-271692

Published: 2010

Journal Articles

Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006).

Blood (2009) 114 (22): 1578.

https://doi.org/10.1182/blood.V114.22.1578.1578

Published: 2009

Journal Articles

Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan.

Marco Zecca, Riccardo Masetti, Adriana Balduzzi, Franca Fagioli, Giorgio Dini, Chiara Messina, Attilio Rovelli, Luca Lo Nigro, Mario Regazzi, Giuseppe Basso, Andrea Pession, Arcangelo Prete, Franco Locatelli

Blood (2009) 114 (22): 2288.

https://doi.org/10.1182/blood.V114.22.2288.2288

Published: 2009

Journal Articles

Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.

Valentino Conter, MD, Maria Grazia Valsecchi, PhD, Maurizio Aricò, Carmelo Rizzari, Rosanna Parasole, Chiara Messina, Giulio De Rossi, Elena Barisone, Luca Lo Nigro, Nicola Santoro, Ottavio Ziino, Franco Locatelli, Andrea Pession, Anna Maria Testi, Concetta Micalizzi, Andrea Biondi, Giuseppe Basso, Daniela Silvestri, Giuseppe Masera, MD

Blood (2009) 114 (22): 319.

https://doi.org/10.1182/blood.V114.22.319.319

Published: 2009

Journal Articles

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Concetta Micalizzi, MD, Rosanna Parasole, Maria Caterina Putti, MD, Matteo Luciani, MD, Laura Banov, MD, Fara Petruzziello, Chiara Messina, Giulio De Rossi

Blood (2008) 112 (11): 3953.

https://doi.org/10.1182/blood.V112.11.3953.3953

Published: 2008

Journal Articles

Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) Treated in the AIEOP-BFM ALL 2000 Study.

Andrea Biondi, André Schrauder, Maria Grazia Valsecchi, Claus R Bartram, Georg Mann, Giulio De Rossi, Anja Möricke, Rosanna Parasole, Jochen Harbott, Chiara Messina, C. Rizzari, Giuseppe Masera, Martin Schrappe

Blood (2008) 112 (11): 1511.

https://doi.org/10.1182/blood.V112.11.1511.1511

Published: 2008

NARROW

Hematopoietic Stem Cell Transplantation for Hemophagocytic Lymphohistiocitosis : A National Retrospective Analysis of Data from the Italian Association of Pediatric Hematology Oncology (AIEOP)

Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience

Role of Allogeneic Hematopoietic Stem Cell Transplantation in t(4;11) Positive Acute Lymphoblastic Leukemia (ALL): A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

High Dose Imatinib Is Effective In Children and Adolescents With Chronic Myelogenous Leukemia In Chronic Phase. The Italian Experience

No Major Complications In Children After Stem Cell Donation At One Year Follow-Up: EBMT Pediatric Diseases Working Party Study

Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry.

Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study

No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study

Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT

Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006).

Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan.

Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.

Clofarabine in Combination with Etoposide and Cyclophosphamide (CLOVE) in Pediatric Patients with Relapsed Acute Leukemia: 4 Italian Pediatric AIEOP Centers’ Experience

Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) Treated in the AIEOP-BFM ALL 2000 Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only